866-997-4948(US-Canada Toll Free)

China Hemophilia Treatment Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 121 Pages

Notes:
Sales, means the sales volume of Hemophilia Treatment Drugs
Revenue, means the sales value of Hemophilia Treatment Drugs

This report studies Hemophilia Treatment Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Pfizer
Biotest
CSL Behring
Kedrion
Octapharma
Shire
Novo Nordisk
Bayer
F. Hoffmann-La Roche
Biogen

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Recombinant Coagulation Factor Concentrates
Plasma Derived Coagulation Factor Concentrates
Desmopressin
Antifibrinolytic Agents
Split by Application, this report focuses on consumption, market share and growth rate of Hemophilia Treatment Drugs in each application, can be divided into
Hemophilia A
Hemophilia B
Others

Table of Contents

China Hemophilia Treatment Drugs Market Research Report 2017
1 Hemophilia Treatment Drugs Market Overview
1.1 Product Overview and Scope of Hemophilia Treatment Drugs
1.2 Hemophilia Treatment Drugs Segment by Type
1.2.1 China Production Market Share of Hemophilia Treatment Drugs Type in 2015
1.2.2 Recombinant Coagulation Factor Concentrates
1.2.3 Plasma Derived Coagulation Factor Concentrates
1.2.4 Desmopressin
1.2.5 Antifibrinolytic Agents
1.3 Applications of Hemophilia Treatment Drugs
1.3.1 Hemophilia Treatment Drugs Consumption Market Share by Application in 2015
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Others
1.4 China Market Size (Value) of Hemophilia Treatment Drugs (2012-2022)
1.5 China Hemophilia Treatment Drugs Status and Outlook
1.6 Government Policies

2 China Hemophilia Treatment Drugs Market Competition by Manufacturers
2.1 China Hemophilia Treatment Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Hemophilia Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Hemophilia Treatment Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Hemophilia Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemophilia Treatment Drugs Market Competitive Situation and Trends
2.5.1 Hemophilia Treatment Drugs Market Concentration Rate
2.5.2 Hemophilia Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Hemophilia Treatment Drugs Manufacturers Profiles/Analysis
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.1.2.1 Recombinant Coagulation Factor Concentrates
3.1.2.2 Plasma Derived Coagulation Factor Concentrates
3.1.3 Pfizer Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Biotest
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.2.2.1 Recombinant Coagulation Factor Concentrates
3.2.2.2 Plasma Derived Coagulation Factor Concentrates
3.2.3 Biotest 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 CSL Behring
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.3.2.1 Recombinant Coagulation Factor Concentrates
3.3.2.2 Plasma Derived Coagulation Factor Concentrates
3.3.3 CSL Behring 131 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Kedrion
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.4.2.1 Recombinant Coagulation Factor Concentrates
3.4.2.2 Plasma Derived Coagulation Factor Concentrates
3.4.3 Kedrion Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Octapharma
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.5.2.1 Recombinant Coagulation Factor Concentrates
3.5.2.2 Plasma Derived Coagulation Factor Concentrates
3.5.3 Octapharma Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Shire
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.6.2.1 Recombinant Coagulation Factor Concentrates
3.6.2.2 Plasma Derived Coagulation Factor Concentrates
3.6.3 Shire Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Novo Nordisk
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.7.2.1 Recombinant Coagulation Factor Concentrates
3.7.2.2 Plasma Derived Coagulation Factor Concentrates
3.7.3 Novo Nordisk Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Bayer
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.8.2.1 Recombinant Coagulation Factor Concentrates
3.8.2.2 Plasma Derived Coagulation Factor Concentrates
3.8.3 Bayer Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 F. Hoffmann-La Roche
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.9.2.1 Recombinant Coagulation Factor Concentrates
3.9.2.2 Plasma Derived Coagulation Factor Concentrates
3.9.3 F. Hoffmann-La Roche Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Biogen
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Hemophilia Treatment Drugs Product Type, Application and Specification
3.10.2.1 Recombinant Coagulation Factor Concentrates
3.10.2.2 Plasma Derived Coagulation Factor Concentrates
3.10.3 Biogen Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview

4 China Hemophilia Treatment Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Hemophilia Treatment Drugs Capacity, Production and Growth (2012-2017)
4.2 China Hemophilia Treatment Drugs Revenue and Growth (2012-2017)
4.3 China Hemophilia Treatment Drugs Production, Consumption, Export and Import (2012-2017)

5 China Hemophilia Treatment Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Hemophilia Treatment Drugs Production and Market Share by Type (2012-2017)
5.2 China Hemophilia Treatment Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Hemophilia Treatment Drugs Price by Type (2012-2017)
5.4 China Hemophilia Treatment Drugs Production Growth by Type (2012-2017)

6 China Hemophilia Treatment Drugs Market Analysis by Application
6.1 China Hemophilia Treatment Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Hemophilia Treatment Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaHemophilia Treatment Drugs Market Analysis by Regions (Provinces)
7.1 China Hemophilia Treatment Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Hemophilia Treatment Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Hemophilia Treatment Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Hemophilia Treatment Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Hemophilia Treatment Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Hemophilia Treatment Drugs Production, Consumption, Export and Import (2012-2017)

8 Hemophilia Treatment Drugs Manufacturing Cost Analysis
8.1 Hemophilia Treatment Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hemophilia Treatment Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hemophilia Treatment Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Hemophilia Treatment Drugs Market Forecast (2017-2022)
12.1 China Hemophilia Treatment Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Hemophilia Treatment Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Hemophilia Treatment Drugs Production Forecast by Type (2017-2022)
12.4 China Hemophilia Treatment Drugs Consumption Forecast by Application (2017-2022)
12.5 China Hemophilia Treatment Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Hemophilia Treatment Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Hemophilia Treatment Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Hemophilia Treatment Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Hemophilia Treatment Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Hemophilia Treatment Drugs
Figure China Production Market Share of Hemophilia Treatment Drugs by Type in 2015
Figure Product Picture of Recombinant Coagulation Factor Concentrates
Table Major Manufacturers of Recombinant Coagulation Factor Concentrates
Figure Product Picture of Plasma Derived Coagulation Factor Concentrates
Table Major Manufacturers of Plasma Derived Coagulation Factor Concentrates
Figure Product Picture of Desmopressin
Table Major Manufacturers of Desmopressin
Figure Product Picture of Antifibrinolytic Agents
Table Major Manufacturers of Antifibrinolytic Agents
Table Hemophilia Treatment Drugs Consumption Market Share by Application in 2015
Figure Hemophilia A Examples
Figure Hemophilia B Examples
Figure Others Examples
Figure China Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Hemophilia Treatment Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Hemophilia Treatment Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Hemophilia Treatment Drugs Capacity of Key Manufacturers in 2015
Figure China Hemophilia Treatment Drugs Capacity of Key Manufacturers in 2016
Table China Hemophilia Treatment Drugs Production of Key Manufacturers (2015 and 2016)
Table China Hemophilia Treatment Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Hemophilia Treatment Drugs Production Share by Manufacturers
Figure 2016 Hemophilia Treatment Drugs Production Share by Manufacturers
Table China Hemophilia Treatment Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Hemophilia Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Hemophilia Treatment Drugs Revenue Share by Manufacturers
Table 2016 China Hemophilia Treatment Drugs Revenue Share by Manufacturers
Table China Market Hemophilia Treatment Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Hemophilia Treatment Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Hemophilia Treatment Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Hemophilia Treatment Drugs Product Type
Figure Hemophilia Treatment Drugs Market Share of Top 3 Manufacturers
Figure Hemophilia Treatment Drugs Market Share of Top 5 Manufacturers
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Hemophilia Treatment Drugs Market Share (2012-2017)
Table Biotest Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotest Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Biotest Hemophilia Treatment Drugs Market Share (2012-2017)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Behring Hemophilia Treatment Drugs Market Share (2012-2017)
Table Kedrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kedrion Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Kedrion Hemophilia Treatment Drugs Market Share (2012-2017)
Table Octapharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Octapharma Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Octapharma Hemophilia Treatment Drugs Market Share (2012-2017)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Shire Hemophilia Treatment Drugs Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Hemophilia Treatment Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Hemophilia Treatment Drugs Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Hemophilia Treatment Drugs Market Share (2012-2017)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Hemophilia Treatment Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Hemophilia Treatment Drugs Market Share (2012-2017)
Figure China Hemophilia Treatment Drugs Capacity, Production and Growth (2012-2017)
Figure China Hemophilia Treatment Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Hemophilia Treatment Drugs Production, Consumption, Export and Import (2012-2017)
Table China Hemophilia Treatment Drugs Production by Type (2012-2017)
Table China Hemophilia Treatment Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Hemophilia Treatment Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Hemophilia Treatment Drugs by Type
Table China Hemophilia Treatment Drugs Revenue by Type (2012-2017)
Table China Hemophilia Treatment Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Hemophilia Treatment Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Hemophilia Treatment Drugs by Type
Table China Hemophilia Treatment Drugs Price by Type (2012-2017)
Figure China Hemophilia Treatment Drugs Production Growth by Type (2012-2017)
Table China Hemophilia Treatment Drugs Consumption by Application (2012-2017)
Table China Hemophilia Treatment Drugs Consumption Market Share by Application (2012-2017)
Figure China Hemophilia Treatment Drugs Consumption Market Share by Application in 2015
Table China Hemophilia Treatment Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Hemophilia Treatment Drugs Consumption Growth Rate by Application (2012-2017)
Table China Hemophilia Treatment Drugs Production by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Hemophilia Treatment Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Treatment Drugs
Figure Manufacturing Process Analysis of Hemophilia Treatment Drugs
Figure Hemophilia Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2015
Table Major Buyers of Hemophilia Treatment Drugs
Table Distributors/Traders List
Figure China Hemophilia Treatment Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Hemophilia Treatment Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Hemophilia Treatment Drugs Production Forecast by Type (2017-2022)
Table China Hemophilia Treatment Drugs Consumption Forecast by Application (2017-2022)
Table China Hemophilia Treatment Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Hemophilia Treatment Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Hemophilia Treatment Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *